These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16266775)

  • 1. How many infective viral particles are necessary for successful mass measles immunization by aerosol?
    Coates AL; Tipples G; Leung K; Gray M; Louca E;
    Vaccine; 2006 Mar; 24(10):1578-85. PubMed ID: 16266775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
    Cohen BJ; Audet S; Andrews N; Beeler J;
    Vaccine; 2007 Dec; 26(1):59-66. PubMed ID: 18063236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines.
    Leung K; Louca E; Gray M; Tipples G; Coates AL
    J Aerosol Med; 2005; 18(4):414-26. PubMed ID: 16379617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project.
    Cohen BJ; Parry RP; Andrews N; Bennett AM; Dennis JH
    Vaccine; 2008 Jun; 26(27-28):3534-9. PubMed ID: 18490082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measles vaccination by the aerosol method in Mexico].
    Fernández-de Castro J; Kumate-Rodríguez J; Sepúlveda J; Ramírez-Isunza JM; Valdespino-Gómez JL
    Salud Publica Mex; 1997; 39(1):53-60. PubMed ID: 9092098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
    Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
    Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles outbreak after a post-honeymoon period in Mongolia, 2001.
    Rentsen T; Enkhtuya B; Nymadawa P; Kobune F; Suzuki K; Yoshida H; Hachiya M
    Jpn J Infect Dis; 2007 Jul; 60(4):198-9. PubMed ID: 17642531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
    Pasetti MF; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams RJ; Polack FP; Ward BJ; Burt D; Chabot S; Ulmer J; Barry EM; Levine MM
    Clin Pharmacol Ther; 2007 Dec; 82(6):672-85. PubMed ID: 17971812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing.
    Restrepo RD; Dickson SK; Rau JL; Gardenhire DS
    Respir Care; 2006 Jan; 51(1):56-61. PubMed ID: 16381619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity against measles among vaccinated school going children in Zahedan, southeast of Iran.
    Mood BS; Naini RN; Salehi M; Kouhpayeh HR; Azad TM; Poor TN
    Indian J Med Microbiol; 2005 Oct; 23(4):274-5. PubMed ID: 16327132
    [No Abstract]   [Full Text] [Related]  

  • 20. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.